Algo version: 0.98b
URGN is listed at the NASDAQ Exchange
URGN [URGN]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is URGN stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for UroGen Pharma Ltd 10 years ago, but if you had invested on Thursday 4th of May 2017 when the price was $13.98, you would have made a loss of $-2.52 per share or -18.03%

Yes, the average daily trading liquidity for UroGen Pharma Ltd is $7.31 million. You should therefore be able to get in and out of your positions relatively fast.

UroGen Pharma Ltd has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for UroGen Pharma Ltd to be high [0.85 out of 1]